XML 36 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 15 - Loss Per Share
12 Months Ended
Sep. 30, 2022
Notes to Financial Statements  
Earnings Per Share [Text Block]

NOTE 15 LOSS PER SHARE

 

The following table sets forth the computation of basic and diluted earnings per share for the following periods:

 

  

Year Ended

 
  

September 30,

  

September 30,

 
  

2022

  

2021

 

Basic:

        

Net income (loss)

 $(70,083,693) $(23,394,889)

Preferred dividends paid

  4,002,005   2,554,609 

Net income (loss) continuing operations adjusted for preferred dividend

  (74,085,698)  (25,949,498)

Net income (loss) attributable to cbdMD Inc. common shareholders

  (74,085,698)  (25,949,498)
         

Diluted:

        

Net income (loss)

  (74,085,698)  (25,949,498)

Net income (loss)

  (74,085,698)  (25,949,498)
         

Shares used in computing basic earnings per share

  59,750,301   54,938,128 

Effect of dilutive securities:

        

Options

  -   - 

Warrants

  -   - 

Convertible preferred shares

  -   - 

Shares used in computing diluted earnings per share

  59,750,301   54,938,128 
         

Earnings per share Basic:

        

Continued operations

  (1.24)  (0.47)

Discontinued operations

  -   - 

Basic earnings per share

  (1.24)  (0.47)
         

Earnings per share Dliuted:

        

Continued operations

  (1.24)  (0.47)

Discontinued operations

  -   - 

Diluted earnings per share

  (1.24)  (0.47)

 

At the year ended  September 30, 2022, 3,335,750 potential shares underlying options, unvested RSUs and warrants as well as 8,335,000 convertible preferred shares were excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.